Immune Evasion Mechanism and AXL

Extensive interest in cancer immunotherapy is reported according to the clinical importance of CTLA-4 and (PD-1/PD-L1) [programmed death (PD) and programmed death-ligand (PD-L1)] in immune checkpoint therapies. AXL is a receptor tyrosine kinase expressed in different types of cancer and in relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Hye-Youn, Jeong, Hwan-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581356/
https://www.ncbi.nlm.nih.gov/pubmed/34778071
http://dx.doi.org/10.3389/fonc.2021.756225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581356/
https://www.ncbi.nlm.nih.gov/pubmed/34778071
http://dx.doi.org/10.3389/fonc.2021.756225

Ejemplares similares